Ann: Half Yearly Report and Accounts, page-28

Can someone explain how a company with a market cap of $6mil has a SP of $1.8? Assuming it is because they have fewer shares on issue (around 3.3 million) and have not had or completed many cap raises in the past. Even with revenue of around the same ~$500k per month this would not mean BOT would be in the same boat as we would have substantially more shares on issue (around 1.1 billion). Quick math would indicate if judging purely on revenue we would need 54x $500k ($27 million) per month revenue to achieve the same SP. Of course revenue is not the only driver and we are biotech spec stock with much higher potential and value of approvals etc. are worth many x amount. Just basing this on revenue alone. That's my assumption and appreciate any insight. Thanks!